Our team of world-class scientists and biotechnology leadership is devoted to discovering breakthrough medicines that change the standard of medical care for patients.
Sir Martin Evans, Nobel Laureate, and Ajan Reginald, former Global Head of Emerging Technologies at Roche, originally founded the company under the name Cell Therapy Ltd (CTL) in 2009. CTL was rebranded as Celixir in 2016.
At Celixir, our values drive all that we do
Specialist – we are dedicated to delivering medical firsts in specific disease areas where innovation is needed
World-class – we collaborate with world leaders in science, medicine and business, leveraging their expertise to inform how we make unprecedented impact
Patient champions – we champion patient needs and ensure they are the first and only motivation for all that we do
Virtuous – we have a track-record of delivering on our promises and operating with integrity in all of our business interactions
Access-driven – our mission is to change the lives of patients in need and this commitment is underpinned by tireless efforts to ensure global access to our medicines
Exceptional – we inspire all employees and partners to reach their full potential and achieve excellence